Drugs / Abacavir/Lamivudine
last change Nov 2009 re-read 2 minutes ago

Abacavir/Lamivudine

Developed for
HIV infectious disease
Investigated by
Denver Infectious Disease Consultants, PLLC · GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00740064 May 2008 → Aug 2009 HIV infectious disease Denver Infectious Disease Consultants, PLLC Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Abacavir/Lamivudine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00740064